Skip to main content
Clinical Trials/NCT06261736
NCT06261736RecruitingNot Applicable

The Effectiveness of Prophylactic Antibiotics for Urethral Bulking

Atlantic Health System2 sites in 1 country70 target enrollmentStarted: October 24, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
70
Locations
2
Primary Endpoint
Rate of urinary tract infection (UTI)

Study Overview

Brief Summary

The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.

Detailed Description

Urethral bulking is a minimally invasive surgical treatment option for stress urinary incontinence (SUI). One commonly reported post-procedural complication is urinary tract infection (UTI). UTI rates are variable where studies have reported rates from as low as 0% to as high as 40%. Along with this variability, the instructional inserts for various bulking agents have inconsistent recommendations for use of prophylactic antibiotics. The American Urologic Association recommends antimicrobial prophylaxis for cystourethroscopy procedures involving minor manipulation. Currently, there are no clear guidelines regarding the utility of prophylactic antibiotics for urethral bulking. The objective of our study is to determine the effectiveness of prophylactic antibiotics in urethral bulking for reducing post procedural UTIs.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients scheduled to undergo a urethral bulking procedure
  • Age 18 ≥ over

Exclusion Criteria

  • History of recurrent urinary tract infections
  • Known history of urinary retention
  • Allergies or contraindications to multiple antibiotics
  • Inability to tolerate oral antibiotics
  • Concomitant surgical procedures at the time of urethral bulking
  • Pregnant or breastfeeding

Arms & Interventions

Antibiotic Group

Experimental

Those randomized to this group will receive a one-time dose of an oral antibiotic prior to the urethral bulking procedure. The antibiotic will be based on the participants' allergies, medical history, and current medication list.

Intervention: Prophylactic antibiotics (Other)

Outcomes

Primary Outcomes

Rate of urinary tract infection (UTI)

Time Frame: Within 4 weeks after the procedure

The rate of UTI based on symptoms and a positive urine culture

Secondary Outcomes

  • Rates of other postoperative complications(Within 4 weeks after the procedure)
  • Rate of postoperative urinary retention(Within 4 weeks after the procedure)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Erika Wasenda

MD

Atlantic Health System

Study Sites (2)

Loading locations...

Similar Trials